" /> Danon disease - CISMeF





Preferred Label : Danon disease;

CISMeF acronym : GSD IIB; GSD2B;

Type : Phenotype, molecular basis known;

Alternative titles and symbols : Vacuolar cardiomyopathy and myopathy, X-linked; Gsd iib; Antopol disease; Glycogen storage disease iib; Pseudoglycogenosis II; Lysosomal glycogen storage disease without acid maltase deficiency; GSD2B;

Description : Danon disease is an X-linked dominant disorder predominantly affecting cardiac muscle. Skeletal muscle involvement and mental retardation are variable features. The accumulation of glycogen in muscle and lysosomes originally led to the classification of Danon disease as a variant of glycogen storage disease II (Pompe disease; 232300) with 'normal acid maltase' or alpha-glucosidase (GAA; 606800) (Danon et al., 1981). However, Nishino et al. (2000) stated that Danon disease is not a glycogen storage disease because glycogen is not always increased. Sugie et al. (2005) classified Danon disease as a form of autophagic vacuolar myopathy, characterized by intracytoplasmic autophagic vacuoles with sarcolemmal features. The characteristic vacuole is believed to be an autolysosome surrounded by secondarily-generated membranes containing sarcolemmal proteins, basal lamina, and acetylcholinesterase activity. X-linked myopathy with excessive autophagy (XMEA; 310440) is a distinct disorder with similar pathologic features.;

Inheritance : X-linked dominant;

Molecular basis : Caused by mutation in the lysosome associated membrane protein-2 gene (LAMP2, 309060.0001);

Laboratory abnormalities : Increased serum creatine kinase;

Prefixed ID : #300257;

Details


You can consult :


Nous contacter.
09/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.